Matthew Alan Walker serves as Executive at GreenLight Biosciences Holdings, PBC, where they oversee executive responsibilities. Since joining the company, Matthew Alan Walker has executed 2 insider transactions totaling $15.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 2, 2022 involved purchasing 1,500,000 shares valued at $15.0M.
Matthew Alan Walker currently holds 15,843,021 shares of GreenLight Biosciences Holdings, PBC (GRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Alan Walker has been a net buyer of GRNA stock. They have purchased $15.0M and sold $0 worth of shares.
Matthew Alan Walker's most recent insider trade was on Feb 2, 2022, when they purchased 1,500,000 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |